
Dermadream operates in the skincare and pharmaceutical industries, focusing on aesthetic product distribution and skincare devices. The company is the exclusive distributor of AestheFill, a dermal filler, in Brazil and actively participates in industry events, such as the Congress of the Brazilian Society of Botulinum Toxin and Facial Aesthetics. In addition to distribution, Dermadream markets its own line of skincare devices under the My Derma Dream brand. This includes the FDA-cleared MicroSculpt microcurrent device, designed to enhance circulation and muscle tone, as well as red light therapy devices aimed at anti-aging. The company targets Brazilian aesthetic professionals and consumers, promoting its products with a 90-day money-back guarantee. Dermadream's dual focus on B2B and B2C markets positions it uniquely within the industry.
We're tracking Dermadream's market expansion
How Dermadream's international expansion compares to its competitors
Bars show relative size across the companies compared.
Columns5| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
DermadreamYou | 0 | 0 | — | 0 | 0 |
Not hiring right now
Sign up to track this company and get alerted the moment something changes.
No active campaigns
Sign up to track this company and get alerted the moment something changes.
Hugel partners with Derma Dream in Brazil to target Latin American botulinum toxin market. Pre-launch events for 'Letybo' held in Rio de Janeiro and São Paulo.
Hugel conducted a 3-day seminar for 60 Brazilian dermatologists to enhance understanding of Letybo brand, including clinic visits, factory tour, and networking sessions.
PharmaResearch signs exclusive supply agreement with DermaDream for Rejuran in Brazil, marking strategic entry into Latin American aesthetic market.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about Dermadream's business, markets, and growth signals.

© 2026 Pubrio. All rights reserved.